Press release
Dementia with Lewy Bodies (DLB) Growing Patient Pool Spurs Demand for Diagnosis and Care Market Expansion
Snippet / Teaser:As medical awareness improves and diagnostic capabilities expand, the global Dementia with Lewy Bodies (DLB) patient pool is growing - creating rising demand for diagnostics, therapies, and long-term care. The DLB market is emerging as a critical segment within dementia care, offering significant opportunities for healthcare providers, pharma, and care services worldwide.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72099
1. Keyword Definition - Dementia with Lewy Bodies (DLB)
Dementia with Lewy Bodies (DLB) is a progressive neurodegenerative disorder characterized by abnormal protein deposits (Lewy bodies) in the brain, leading to cognitive decline, fluctuating alertness, visual hallucinations, Parkinsonism (movement symptoms), and sleep and behavioral disturbances. DLB is one of the more common forms of dementia after Alzheimer's disease, and because symptoms often overlap with other dementias and Parkinson's disease, accurate diagnosis and long-term management are especially critical.
DLB requires comprehensive care - including symptomatic therapy, neuropsychiatric support, dementia-care services, and often long-term assisted living - placing it among the most challenging dementia sub-types.
2. Key Stakeholders in the DLB Market
The DLB market ecosystem comprises:
• Pharmaceutical and biotech companies developing neurodegenerative-disease therapies, symptomatic dementia treatments, and neuroprotective agents.
• Diagnostic service providers offering cognitive assessment, imaging, biomarker assays, and differential-diagnosis testing to distinguish DLB from other dementias.
• Hospitals, neurology and memory clinics, dementia-care centers, long-term care and assisted-living facilities, and home-care providers managing patient care across disease stages.
• Caregiver services, social-support networks, behavioral therapy and neuropsychiatric support, rehabilitation services, and palliative care providers for long-term disease management.
• Research institutions, health-policy bodies, and dementia advocacy organizations raising awareness, improving diagnosis protocols, and promoting patient support services.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/72099/dementia-with-lewy-bodies-patient-pool-analysis-market
3. Recent Trends & Key Drivers in DLB Market Dynamics
• Growing clinical recognition of DLB as distinct from other dementias - leading to increased diagnosis rates and better patient identification.
• Improved diagnostic tools and protocols (clinical assessments, imaging, biomarker research) - helping differentiate DLB from Alzheimer's and Parkinson's, thus raising confirmed case numbers.
• Rising global elderly population and corresponding increase in neurodegenerative disorders - expanding the potential DLB patient pool.
• Greater demand for specialized dementia-care services, assisted living, neuropsychiatric support, and long-term care facilities - reflecting the complex, chronic nature of DLB.
• Increased interest from pharmaceutical and biotech companies in developing therapies targeting neurodegeneration, symptom management, and dementia-related cognitive and behavioral symptoms.
• Growth in caregiver support networks, home-care services, and dementia-friendly healthcare infrastructure - improving access to long-term care even in emerging regions.
4. Market Outlook & Growth Potential
• As diagnosis rates rise globally and awareness improves, the addressable patient pool for DLB is expected to grow significantly - increasing demand for both diagnostics and care services.
• Demand for symptomatic therapies, neuropsychiatric management, supportive care, rehabilitation, and long-term assisted living will grow alongside rising patient numbers.
• Regions with aging populations and expanding healthcare infrastructure are expected to see the fastest growth in the DLB care market.
• Over the next decade, the DLB market is likely to expand steadily - encompassing diagnostics, therapeutic management, long-term care, and support services - representing a growing portion of the global dementia care industry.
5. Key Market Segments and Service Types
By Service / Treatment Type:
• Symptomatic therapies for cognitive and behavioral symptoms
• Neuropsychiatric treatments and supportive care (sleep, hallucinations, mood, behavior)
• Diagnostic and monitoring services (imaging, biomarker analysis, cognitive assessments)
• Long-term care: memory clinics, assisted-living facilities, home-care support
• Rehabilitation, physical therapy, occupational therapy, caregiver support
By Care Setting:
• Memory-care centers and specialized dementia clinics
• Hospitals and neurology departments
• Assisted-living / long-term care facilities
• Home-based care and outpatient services
• Diagnostic and monitoring laboratories
By Geography / Region:
• High-income regions with advanced healthcare and aging populations - early majority share
• Middle-income and emerging regions - fastest growth potential as awareness, diagnostics, and care infrastructure improve
Get Your Exclusive Offer with up to 10% Discount
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72099
6. Challenges and Market Barriers
• Diagnostic complexity: overlapping symptoms with Alzheimer's, Parkinson's, and other dementias - requiring careful differential diagnosis and skilled neurologists
• Limited disease-modifying therapies specifically for DLB; mostly symptomatic treatments are available currently
• High cost of long-term care, dementia care facilities, and supportive services - limiting access in lower-income regions
• Need for trained specialists (neurologists, geriatric psychiatrists, dementia care professionals) and supportive infrastructure for long-term management
• Social stigma, lack of awareness in many regions, and limited public health resources for dementia care
Despite these challenges, rising awareness and expanding care infrastructure continue to drive market viability.
7. Conclusion
The Dementia with Lewy Bodies (DLB) market is emerging as an increasingly important segment in global dementia care, driven by rising disease recognition, growing elderly populations, and increasing demand for comprehensive care. As patient diagnosis improves and supportive-care services expand, the market - covering diagnostics, symptomatic therapy, long-term care, and rehabilitation - is set for sustained growth. For pharmaceutical firms, care-service providers, and dementia-care stakeholders, DLB represents a growing opportunity in the broader neurodegenerative and dementia-care landscape.
This report is also available in the following languages : Japanese (レビー小体型認知症患者プール分析、市場), Korean (루이소체 치매 환자 풀 분석, 시장), Chinese (路易体痴呆症患者群体分析、市场), French (Analyse du marché des patients atteints de démence à corps de Lewy), German (Patientenpoolanalyse bei Lewy-Körperchen-Demenz, Markt), and Italian (Analisi del pool di pazienti affetti da demenza con corpi di Lewy, mercato), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/72099
Our More Reports:
Spinal Muscular Atrophy Market
https://exactitudeconsultancy.com/reports/72075/spinal-muscular-atrophy-market
Tardive Dyskinesia Market
https://exactitudeconsultancy.com/reports/72077/tardive-dyskinesia-market
Transverse Myelitis Market
https://exactitudeconsultancy.com/reports/72079/transverse-myelitis-market
Tropical Spastic Paraparesis Market
https://exactitudeconsultancy.com/reports/72081/tropical-spastic-paraparesis-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Dementia with Lewy Bodies (DLB) Growing Patient Pool Spurs Demand for Diagnosis and Care Market Expansion here
News-ID: 4304518 • Views: …
More Releases from Exactitude Consultancy
Diabetic Eye Disease Market to Reach USD 13.84 Billion by 2034
Pune, India - December 2025 - The global Diabetic Eye Disease Market, valued at USD 7.89 billion in 2024, is projected to reach USD 13.84 billion by 2034, growing at a 5.8% CAGR (2025-2034), according to Exactitude Consultancy. Rising global diabetes burden, increasing screening rates, and advancements in retinal imaging and anti-VEGF therapies are significantly expanding the market.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72009
Market Summary
The Diabetic Eye…
Contrast-Induced Nephropathy (CIN) Market to Reach USD 1.92 Billion by 2034
Pune, India - December 2025 - The global Contrast-Induced Nephropathy (CIN) Market, valued at USD 1.14 billion in 2024, is projected to reach USD 1.92 billion by 2034, growing at a 5.4% CAGR (2025-2034), according to Exactitude Consultancy. With rising use of contrast-enhanced imaging procedures and growing incidence of chronic kidney disease (CKD), diabetes, and cardiovascular disorders, demand for CIN prevention and management solutions is rising steadily.
Download Full PDF Sample…
Alzheimer's Disease Market Set for Major Growth Demand 2034
With global demographic shifts toward older populations and breakthroughs in diagnostics and therapy, the Alzheimer's disease market is poised for significant growth. Rising prevalence, increasing early detection, and greater demand for care make Alzheimer's a key growth area for healthcare stakeholders worldwide.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72097
1. Keyword Definition - Alzheimer's Disease (AD)
Alzheimer's Disease (AD) is a progressive neurodegenerative condition characterized by memory loss, cognitive decline, impaired…
Adrenal Insufficiency Market to Reach USD 4.03 Billion by 2034
Pune, India - December 2025 - The global Adrenal Insufficiency Market, valued at USD 2.38 billion in 2024, is projected to reach USD 4.03 billion by 2034, growing at a 5.4% CAGR (2025-2034), according to Exactitude Consultancy. Rising prevalence of autoimmune disorders, enhanced diagnostic awareness, and advancements in glucocorticoid replacement therapies are fueling consistent market growth.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72005
Market Summary
The Adrenal Insufficiency Market is…
More Releases for DLB
Lewy Body Dementia Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials E …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Lewy Body Dementia pipeline constitutes key companies continuously working towards developing Lewy Body Dementia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Lewy Body Dementia Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a…
Dementia with Lewy Bodies (DLB) Market is expected to reach 6.8 million by 2034
Dementia with Lewy bodies (DLB) is the second most common form of progressive dementia after Alzheimer's disease, accounting for 10-15% of dementia cases worldwide. It is characterized by the abnormal buildup of alpha-synuclein proteins (Lewy bodies) in the brain, leading to cognitive decline, fluctuations in alertness, Parkinsonian motor symptoms, sleep disturbances, and hallucinations.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72099
The complexity of DLB often leads to underdiagnosis or…
Lewy Body Dementia Market Set to Grow Substantially Through 2034, DelveInsight P …
DelveInsight's "Lewy Body Dementia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Lewy Body Dementia, historical and forecasted epidemiology as well as the Lewy Body Dementia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Lewy Body Dementia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Lewy Body Dementia Market…
Lewy Body Dementia Market to Show Remarkable Growth Trends from 2024 to 2034, De …
DelveInsight's "Lewy Body Dementia Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Lewy Body Dementia, historical and forecasted epidemiology as well as the Lewy Body Dementia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Lewy Body Dementia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Lewy Body Dementia Market…
Lewy Body Dementia Pipeline 2025: FDA Approvals and Clinical Trials Landscape wi …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Lewy Body Dementia pipeline constitutes key companies continuously working towards developing Lewy Body Dementia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Lewy Body Dementia Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report…
Lewy Body Dementia Pipeline Assessment 2024: Therapies, Clinical Trials, Key Com …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Lewy Body Dementia pipeline constitutes key companies continuously working towards developing Lewy Body Dementia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Lewy Body Dementia Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a…
